SEC Form 4 · accession 0001019687-16-005303
Sonoma Pharmaceuticals, Inc. · SNOA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James J Schutz
Officer — Chief Executive Officer · Director
Period of report
Feb 25, 2016
Accepted (ET)
Feb 29, 2016 · 6:00 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367083
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 25, 2016 | P | 5,000 | $0.9999 | A | 25,885 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Mr. Schutz purchased these shares in the open market.